PROVIDER PROFILE · NPI 1811979974

Michael Finn

Internal MedicineSlidell, LAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

253

Beneficiaries

—

Total drug cost

$58K

Distinct drugs

Brand share

26.1%

Top prescribed drugs

Metoprolol Succinate43 claims

Apixaban39 claims

Furosemide28 claims

Ezetimibe26 claims

Atorvastatin Calcium25 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$192

Payment records

By payment type

Food and Beverage$192

REFERRAL NETWORK

Where Michael Finn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 39 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Farhad Aduli Interventional Cardiology · Covington, LA	273	861
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	200	612
NPI 1386646586	150	483
Beata Silvestri Diagnostic Radiology · Lacombe, LA	134	388
Adriana Nagy Cardiology · Covington, LA	132	235
James Silvestri Diagnostic Radiology · Lacombe, LA	82	240
NORTH OAKS MEDICAL CENTER, LLC	50	139
OUR LADY OF THE ANGELS HOSPITAL, INC.	47	168
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	46	95
SANDERS, RICHARD	45	193
LEVY, DAVID	37	55
Barry Kusnick Interventional Cardiology · Daytona Beach, FL	35	132

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history